{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:09:10Z","timestamp":1791410950137,"version":"4.3.3"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T00:00:00Z","timestamp":1508716800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroImage: Clinical"],"published-print":{"date-parts":[[2018]]},"DOI":"10.1016\/j.nicl.2017.10.022","type":"journal-article","created":{"date-parts":[[2017,11,6]],"date-time":"2017-11-06T03:30:17Z","timestamp":1509939017000},"page":"263-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"special_numbering":"C","title":["Neuroimaging and other modalities to assess Alzheimer's disease in Down syndrome"],"prefix":"10.1016","volume":"17","author":[{"given":"Natalie","family":"Neale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concepcion","family":"Padilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana Mascarenhas","family":"Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1639-6014","authenticated-orcid":false,"given":"Shahid","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.nicl.2017.10.022_bb0005","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.jalz.2015.07.490","article-title":"The pattern of amyloid accumulation in the brains of adults with Down syndrome","volume":"12","author":"Annus","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nicl.2017.10.022_bb0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neurobiolaging.2017.01.009","article-title":"The Down syndrome brain in the presence and absence of fibrillar \u03b2-amyloidosis","volume":"53","author":"Annus","year":"2017","journal-title":"Neurobiol. Aging"},{"issue":"10","key":"10.1016\/j.nicl.2017.10.022_bb0015","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nrg1448","article-title":"Chromosome 21 and Down syndrome: from genomics to pathophysiology","volume":"5","author":"Antonarakis","year":"2004","journal-title":"Nat. Rev. Genet."},{"issue":"8","key":"10.1016\/j.nicl.2017.10.022_bb0020","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.clinph.2010.02.155","article-title":"Cortical sources of EEG rhythms are abnormal in Down syndrome","volume":"121","author":"Babiloni","year":"2010","journal-title":"Clin. Neurophysiol."},{"issue":"4","key":"10.1016\/j.nicl.2017.10.022_bb0025","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1017\/S0033291708004054","article-title":"Alzheimer's disease and Down's syndrome: an in vivo MRI study","volume":"39","author":"Beacher","year":"2009","journal-title":"Psychol. Med."},{"issue":"4","key":"10.1016\/j.nicl.2017.10.022_bb0030","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1017\/S0033291709990985","article-title":"Brain anatomy and ageing in non-demented adults with Down's syndrome: an in vivo MRI study","volume":"40","author":"Beacher","year":"2010","journal-title":"Psychol. Med."},{"issue":"5","key":"10.1016\/j.nicl.2017.10.022_bb0035","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1167\/iovs.06-1029","article-title":"Retinal abnormalities in early Alzheimer's disease","volume":"48","author":"Berisha","year":"2007","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"7","key":"10.1016\/j.nicl.2017.10.022_bb0040","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1056\/NEJM200008173430701","article-title":"Patterns of brain activation in people at risk for Alzheimer's disease","volume":"343","author":"Bookheimer","year":"2000","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nicl.2017.10.022_bb0045","series-title":"Down Syndrome: Current Perspectives","article-title":"Advances in molecular genetics","author":"Bouman","year":"2015"},{"issue":"338","key":"10.1016\/j.nicl.2017.10.022_bb0050","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaf2362","article-title":"Tau and A\u03b2 imaging, CSF measures, and cognition in Alzheimer's disease","volume":"8","author":"Brier","year":"2016","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.nicl.2017.10.022_bb0055","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S0896-6273(02)00604-9","article-title":"Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome","volume":"33","author":"Busciglio","year":"2002","journal-title":"Neuron"},{"issue":"12","key":"10.1016\/j.nicl.2017.10.022_bb0060","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1001\/archneurol.2009.279","article-title":"Absence of Pittsburgh compound B detection of cerebral amyloid \u0392 in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: a case report","volume":"66","author":"Cairns","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nicl.2017.10.022_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2017.10.004","article-title":"Searching for new pharmalogical targets for the treatment of Alzheimers disease in Down syndrome","author":"Caraci","year":"2017","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.nicl.2017.10.022_bb0070","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1007\/s00415-016-8308-8","article-title":"Alzheimer's disease in people with Down's syndrome: the prospects for and the challenges of developing preventative treatments","volume":"264","author":"Castro","year":"2016","journal-title":"J. Neurol."},{"key":"10.1016\/j.nicl.2017.10.022_bb0075","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/B978-0-12-394816-8.00002-7","article-title":"Using Pittsburgh compound B for in vivo PET imaging of fibrillar amyloid-beta","volume":"64","author":"Cohen","year":"2012","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.nicl.2017.10.022_bb0080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.neurobiolaging.2017.04.006","article-title":"Brain-predicted age in Down syndrome is associated with beta amyloid deposition and cognitive decline","volume":"56","author":"Cole","year":"2017","journal-title":"Neurobiol. Aging"},{"issue":"9","key":"10.1016\/j.nicl.2017.10.022_bb0095","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1016\/j.neurobiolaging.2007.02.029","article-title":"Alzheimer's disease-type neuronal tau hyperphosphorylation induced by A beta oligomers","volume":"29","author":"De Felice","year":"2008","journal-title":"Neurobiol. Aging"},{"issue":"1","key":"10.1016\/j.nicl.2017.10.022_bb0100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.3233\/JAD-161112","article-title":"Anomalous white matter structure and the effect of age in Down syndrome patients","volume":"57","author":"Fenoll","year":"2017","journal-title":"J. Alzheimers Dis."},{"issue":"3\u20134","key":"10.1016\/j.nicl.2017.10.022_bb0105","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1159\/000442941","article-title":"Frontal lobe degeneration in adults with Down syndrome and Alzheimer's disease: a review","volume":"41","author":"Fonseca","year":"2016","journal-title":"Dement. Geriatr. Cogn. Disord."},{"issue":"4791","key":"10.1016\/j.nicl.2017.10.022_bb5000","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1126\/science.3810169","article-title":"Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer\u2019s disease","volume":"235","author":"Goldgaber","year":"1987","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.nicl.2017.10.022_bb0110","first-page":"1","article-title":"Quantification of tau load using [18F]AV1451 PET","author":"Golla","year":"2017","journal-title":"Mol. Imaging Biol."},{"issue":"5534","key":"10.1016\/j.nicl.2017.10.022_bb0115","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1126\/science.1062097","article-title":"Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils","volume":"293","author":"G\u00f6tz","year":"2001","journal-title":"Science (New York, N.Y.)"},{"issue":"3","key":"10.1016\/j.nicl.2017.10.022_bb0120","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1016\/j.neuroimage.2007.09.064","article-title":"Neuro-imaging of individuals with Down syndrome at-risk for dementia: evidence for possible compensatory events","volume":"39","author":"Haier","year":"2008","journal-title":"NeuroImage"},{"issue":"6","key":"10.1016\/j.nicl.2017.10.022_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jalz.2011.09.229","article-title":"Imaging brain amyloid in nondemented young adults with Down syndrome using Pittsburgh compound B","volume":"8","author":"Handen","year":"2012","journal-title":"Alzheimers Dement."},{"issue":"9","key":"10.1016\/j.nicl.2017.10.022_bb0130","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1093\/brain\/awu173","article-title":"Cognitive functioning in relation to brain amyloid-\u03b2 in healthy adults with Down syndrome","volume":"137","author":"Hartley","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.nicl.2017.10.022_bb0135","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1192\/bjp.172.6.493","article-title":"Population-based study of the prevalence and presentation of dementia in adults with Down's syndrome","volume":"172","author":"Holland","year":"1998","journal-title":"Br. J. Psychiatry J. Ment. Sci."},{"issue":"2","key":"10.1016\/j.nicl.2017.10.022_bb0140","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1046\/j.1365-2788.2000.00263.x","article-title":"Incidence and course of dementia in people with Down's syndrome: findings from a population-based study","volume":"44","author":"Holland","year":"2000","journal-title":"J. Intellect. Disabil. Res."},{"issue":"6","key":"10.1016\/j.nicl.2017.10.022_bb0145","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/brain\/awn016","article-title":"Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease","volume":"131","author":"Ikonomovic","year":"2008","journal-title":"Brain"},{"issue":"1","key":"10.1016\/j.nicl.2017.10.022_bb0150","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.wno.0000204645.56873.26","article-title":"Relationship between cognitive impairment and retinal morphological and visual functional abnormalities in Alzheimer disease","volume":"26","author":"Iseri","year":"2006","journal-title":"J. Neuroophthalmol."},{"issue":"3","key":"10.1016\/j.nicl.2017.10.022_bb0155","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/ana.410370305","article-title":"Amyloid \u03b2 protein (A\u03b2) deposition: A\u03b242(43) precedes A\u03b240 in Down syndrome","volume":"37","author":"Iwatsubo","year":"1995","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.nicl.2017.10.022_bb0160","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1212\/WNL.0000000000001212","article-title":"Age dependence of brain \u03b2-amyloid deposition in Down syndrome an [18F]florbetaben PET study","volume":"84","author":"Jennings","year":"2015","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.nicl.2017.10.022_bb0165","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ana.24546","article-title":"Tau positron emission tomographic imaging in aging and early Alzheimer disease","volume":"79","author":"Johnson","year":"2015","journal-title":"Ann. Neurol."},{"issue":"23","key":"10.1016\/j.nicl.2017.10.022_bb0170","doi-asserted-by":"crossref","first-page":"6174","DOI":"10.1523\/JNEUROSCI.0730-07.2007","article-title":"Amyloid deposition begins in the striatum of Presenilin-1 mutation carriers from two unrelated pedigrees","volume":"27","author":"Klunk","year":"2007","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.nicl.2017.10.022_bb0175","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/archneurol.2011.36","article-title":"Using positron emission tomography and carbon 11\u2013labeled pittsburgh compound B to image brain fibrillar \u03b2-amyloid in adults with Down syndrome: safety, acceptability, and feasibility","volume":"68","author":"Landt","year":"2011","journal-title":"Arch. Neurol."},{"issue":"4","key":"10.1016\/j.nicl.2017.10.022_bb0180","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jalz.2015.05.013","article-title":"The effects of normal aging on amyloid-\u03b2 deposition in nondemented adults with Down syndrome as imaged by carbon 11\u2013labeled Pittsburgh compound B","volume":"12","author":"Lao","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.nicl.2017.10.022_bb0185","first-page":"1","article-title":"Longitudinal changes in amyloid positron emission tomography and volumetric magnetic resonance imaging in the nondemented Down syndrome population","volume":"9","author":"Lao","year":"2017","journal-title":"Alzheimers Dement."},{"issue":"7","key":"10.1016\/j.nicl.2017.10.022_bb0190","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1093\/cercor\/bhv107","article-title":"Dissociations in Cortical morphometry in youth with Down syndrome: evidence for reduced surface area but increased thickness","volume":"26","author":"Lee","year":"2016","journal-title":"Cereb. Cortex"},{"issue":"1","key":"10.1016\/j.nicl.2017.10.022_bb0195","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1006\/nbdi.1996.0003","article-title":"Sequence of deposition of heterogeneous amyloid beta-peptides and APO E in Down syndrome: implications for initial events in amyloid plaque formation","volume":"3","author":"Lemere","year":"1996","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nicl.2017.10.022_bb0200","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.neurobiolaging.2017.03.005","article-title":"Down syndrome: age-dependence of PiB binding in postmortem frontal cortex across the lifespan","volume":"54","author":"LeVine","year":"2017","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nicl.2017.10.022_bb0205","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.nicl.2016.06.001","article-title":"1H-MRS metabolites in adults with Down syndrome: effects of dementia","volume":"11","author":"Lin","year":"2016","journal-title":"NeuroImage"},{"issue":"9","key":"10.1016\/j.nicl.2017.10.022_bb0210","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1096\/fj.07-104539","article-title":"Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndrome","volume":"22","author":"Liu","year":"2008","journal-title":"FASEB J."},{"issue":"10","key":"10.1016\/j.nicl.2017.10.022_bb0215","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1093\/brain\/awm191","article-title":"PIB is a non-specific imaging marker of amyloid-beta (A\u03b2) peptide-related cerebral amyloidosis","volume":"130","author":"Lockhart","year":"2007","journal-title":"Brain"},{"issue":"3","key":"10.1016\/j.nicl.2017.10.022_bb0220","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/j.1365-2990.1984.tb00351.x","article-title":"Alzhiemer's dementia, presenile dementia, senile dementia of Alzheimer's type and Down's syndrome in middle age form an age related continuum of pathological changes","volume":"10","author":"Mann","year":"1984","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"6","key":"10.1016\/j.nicl.2017.10.022_bb0225","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1111\/j.1365-2788.2006.00902.x","article-title":"Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: incidence of cognitive decline, its relationship to age and neuropathology","volume":"51","author":"Margallo-Lana","year":"2007","journal-title":"J. Intellect. Disabil. Res."},{"issue":"2","key":"10.1016\/j.nicl.2017.10.022_bb0230","first-page":"69","article-title":"Dissociation of Down syndrome and Alzheimer's disease effects with imaging","volume":"2","author":"Matthews","year":"2016","journal-title":"Alzheimers Dement."},{"issue":"4","key":"10.1016\/j.nicl.2017.10.022_bb0235","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2147\/NDT.S3381","article-title":"Diffusion tensor imaging investigations in Alzheimer's disease: the resurgence of white matter compromise in the cortical dysfunction of the aging brain","volume":"4","author":"Medina","year":"2008","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"1","key":"10.1016\/j.nicl.2017.10.022_bb0240","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/ana.410420114","article-title":"Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease","volume":"42","author":"Minoshima","year":"1997","journal-title":"Ann. Neurol."},{"issue":"5","key":"10.1016\/j.nicl.2017.10.022_bb0245","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0010659","article-title":"Alzheimer's disease amyloid-beta links lens and brain pathology in Down syndrome","volume":"5","author":"Moncaster","year":"2010","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.nicl.2017.10.022_bb0250","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1001\/archneurol.2011.104","article-title":"Positron emission tomography of brain \u03b2-amyloid and tau levels in adults with Down syndrome","volume":"68","author":"Nelson","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nicl.2017.10.022_bb0255","series-title":"Down Syndrome: Current Perspectives","article-title":"Neuropsychiatry of Down syndrome","author":"Newton","year":"2015"},{"key":"10.1016\/j.nicl.2017.10.022_bb0260","series-title":"Down Syndrome: Current Perspectives","author":"Newton","year":"2015"},{"issue":"8","key":"10.1016\/j.nicl.2017.10.022_bb0265","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1007\/s00415-014-7376-x","article-title":"Progressive myoclonus epilepsy in Down syndrome patients with dementia","volume":"261","author":"d'Orsi","year":"2014","journal-title":"J. Neurol."},{"issue":"7","key":"10.1016\/j.nicl.2017.10.022_bb0270","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.neurobiolaging.2014.01.137","article-title":"Frontal white matter integrity in adults with Down syndrome with and without dementia","volume":"35","author":"Powell","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nicl.2017.10.022_bb0275","series-title":"Down Syndrome: Current Perspectives","article-title":"Antenatal diagnosis: giving the news","author":"Puri","year":"2015"},{"issue":"4","key":"10.1016\/j.nicl.2017.10.022_bb0280","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer's disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.nicl.2017.10.022_bb0285","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2015.00239","article-title":"The Down syndrome biomarker initiative (DSBI) pilot: proof of concept for deep phenotyping of Alzheimer's disease biomarkers in Down syndrome","volume":"9","author":"Rafii","year":"2015","journal-title":"Front. Behav. Neurosci."},{"issue":"2","key":"10.1016\/j.nicl.2017.10.022_bb0290","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00401-009-0583-3","article-title":"Deficient high-affinity binding of Pittsburgh compound B in a case of Alzheimer's disease","volume":"119","author":"Rosen","year":"2010","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.nicl.2017.10.022_bb0295","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/1567205012666150921095724","article-title":"Clinical assessment of cognitive decline in adults with Down syndrome","volume":"13","author":"Sabbagh","year":"2015","journal-title":"Curr. Alzheimer Res."},{"issue":"11","key":"10.1016\/j.nicl.2017.10.022_bb0300","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1001\/archneurol.2011.535","article-title":"Positron emission tomography and neuropathologic estimates of fibrillar amyloid-\u03b2 in a patient with Down syndrome and Alzheimer disease","volume":"68","author":"Sabbagh","year":"2011","journal-title":"Arch. Neurol."},{"issue":"8","key":"10.1016\/j.nicl.2017.10.022_bb0305","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.jalz.2015.01.006","article-title":"Florbetapir PET, FDG PET, and MRI in Down syndrome individuals with and without Alzheimer's dementia","volume":"11","author":"Sabbagh","year":"2015","journal-title":"Alzheimers Dement."},{"issue":"3","key":"10.1016\/j.nicl.2017.10.022_bb0310","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1159\/000438857","article-title":"Quantitative electroencephalography as a diagnostic tool for Alzheimer's dementia in adults with Down syndrome","volume":"5","author":"Salem","year":"2015","journal-title":"Dementia and Geriatric Cognitive Disorders Extra"},{"issue":"6","key":"10.1016\/j.nicl.2017.10.022_bb0315","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/j.ridd.2013.02.021","article-title":"Incidence of dementia in older adults with intellectual disabilities","volume":"34","author":"Strydom","year":"2013","journal-title":"Res. Dev. Disabil."},{"issue":"12","key":"10.1016\/j.nicl.2017.10.022_bb0320","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A beta-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.nicl.2017.10.022_bb0325","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/biof.184","article-title":"Mitochondrial dysfunction and Down's syndrome: is there a role for coenzyme Q10?","volume":"37","author":"Tiano","year":"2011","journal-title":"Biofactors"},{"issue":"84","key":"10.1016\/j.nicl.2017.10.022_bb0330","article-title":"Down's syndrome, neuroinflammation, and Alzheimer neuropathogenesis","volume":"10","author":"Wilcock","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.nicl.2017.10.022_bb0335","series-title":"Doctoral Thesis","article-title":"Brain connectivity in people with Down's syndrome: influences of atypical development and Alzheimer's disease neuropathology","author":"Wilson","year":"2016"},{"key":"10.1016\/j.nicl.2017.10.022_bb0340","series-title":"Intellectual Disability and Dementia: Research into Practice","article-title":"Understanding the process: links between Down syndrome and dementia","author":"Wilson","year":"2014"},{"issue":"10","key":"10.1016\/j.nicl.2017.10.022_bb0350","doi-asserted-by":"crossref","first-page":"6021","DOI":"10.1074\/jbc.R800013200","article-title":"Tau mutations in neurodegenerative diseases","volume":"284","author":"Wolfe","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.nicl.2017.10.022_bb0355","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jmb.2007.04.014","article-title":"A\u03b240 protects non-toxic A\u03b242 monomer from aggregation","volume":"369","author":"Yan","year":"2007","journal-title":"J. Mol. Biol."},{"issue":"3","key":"10.1016\/j.nicl.2017.10.022_bb0360","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/mrdd.20163","article-title":"Alzheimer's disease in Down syndrome: neurobiology and risk","volume":"13","author":"Zigman","year":"2007","journal-title":"Ment. Retard. Dev. Disabil. Res. Rev."},{"issue":"1","key":"10.1016\/j.nicl.2017.10.022_bb0365","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/alzrt24","article-title":"Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy","volume":"2","author":"Zotova","year":"2010","journal-title":"Alzheimers Res. Ther."}],"container-title":["NeuroImage: Clinical"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158217302644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213158217302644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T04:10:35Z","timestamp":1761970235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213158217302644"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":71,"alternative-id":["S2213158217302644"],"URL":"https:\/\/doi.org\/10.1016\/j.nicl.2017.10.022","relation":{},"ISSN":["2213-1582"],"issn-type":[{"value":"2213-1582","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuroimaging and other modalities to assess Alzheimer's disease in Down syndrome","name":"articletitle","label":"Article Title"},{"value":"NeuroImage: Clinical","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nicl.2017.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}